calpain II inhibitor (NeurAegis)

N/A

Report date: 2025/06/11 10:38:47
NME

Base Information

Drug Namecalpain II inhibitor (NeurAegis)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionCalpain-2 catalytic subunit inhibitors
TargetsCalpain-2 catalytic subunit
Therapy Area/IndicationsHearing Loss, Noise-Induced
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesWestern University Of Health Sciences
China Registration ClassN/A

Develop Information

Active CompaniesNeurAegis Inc
Inactive CompaniesN/A
Active IndicationsHearing Loss, Noise-Induced
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A